Inactive Instrument

News ERYTECH Pharma LIQUIDNET SYSTEMS

Equities

FR0011471135

Summary

Unlock all the news: Be the first to know and act before the market!

Phaxiam: EPIC Bpifrance exceeds 25% of share capital	03/07	CF
PHAXIAM Therapeutics S A : announces the success of its rights issue of €7.8m	28/06	PU
Results of the Combined General Meeting of 28 June 2024	28/06	GL
Results of the Combined General Meeting of 28 June 2024	28/06	AQ
Would you like some more inflation?	28/06
Phaxiam: fewer funds raised than expected	28/06	CF
Phaxiam: capital increase of ten million euros	12/06	CF
PHAXIAM announces the availability of the preparatory documents for the Combined General Meeting of 28 June 2024	07/06	GL
PHAXIAM provides Business and Financial Update for the First Quarter of 2024	15/05	GL
Phaxiam initiates trial in infective endocarditis	15/04	CF
PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus	15/04	GL
PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus	15/04	CI
PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)	05/04	GL
Transcript : PHAXIAM Therapeutics S.A., Q4 2023 Earnings Call, Mar 21, 2024	21/03
PHAXIAM Announces 2023 Full-Year Results and Provides Business Update	20/03	GL
PHAXIAM Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
PHAXIAM Therapeutics Completes Delisting of ADS From Nasdaq	11/03	MT
Phaxiam Therapeutics Delists from Nasdaq Capital Market	11/03	MT
PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market	11/03	GL
PHAXIAM Therapeutics S.A.(NasdaqCM:PHXM) dropped from NASDAQ Composite Index	08/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ERYTECH Pharma LIQUIDNET SYSTEMS

Equities

FR0011471135

Summary

Filters